VALANX Biotech
PrivateLast Round
Series A
Mar 12, 2026
Total Funding Raised
$3.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VALANX Biotech is a biotechnology company that has developed a proprietary platform for site-specific protein conjugation to create antibody-drug conjugates (ADCs) and other biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VALANX Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
VALANX Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 12, 2026 | ||||
| VC Round | Nov 7, 2023 | ||||
| Seed | May 1, 2020 | ||||
| Accelerator | Jun 16, 2017 |
VALANX Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| tecnet equity | Seed, Series A, VC Round |
| Skygene | Series A, VC Round |
| xista science ventures | Seed, VC Round |
| xista science ventures | Series A |
| RebelBio | Accelerator |
| SOSV | Seed, Series A, VC Round, Accelerator |
| Fondation Fournier-Majoie | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
Grew 21% QoQ, from 14 to 17 employees.
- Apr 15, 2026
Monthly visitors increased 144% MoM, reaching 268.
VALANX Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about VALANX Biotech's valuation, stock price, and market status.